| FINVX | LIDAX | FINVX / LIDAX | |
| Total Expense Ratio | 0.01 | 0.99 | 1% |
| Annual Report Gross Expense Ratio | 0.01 | 0.99 | 1% |
| Fund Existence | 16 years | 18 years | - |
| Gain YTD | 2.756 | 2.089 | 132% |
| Front Load | N/A | 6% | - |
| Min. Initial Investment | 0 | 1500 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 16.5B | 506M | 3,261% |
| Annual Yield % from dividends | 4.35 | 2.56 | 170% |
| Returns for 1 year | 41.84 | 43.11 | 97% |
| Returns for 3 years | 69.26 | 62.34 | 111% |
| Returns for 5 years | 86.00 | 55.91 | 154% |
| Returns for 10 years | 140.92 | 116.27 | 121% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BEGS | 26.84 | 0.89 | +3.42% |
| Rareview 2X Bull Cryptoccy & Prc Mtl ETF | |||
| PPH | 105.46 | -0.16 | -0.15% |
| VanEck Pharmaceutical ETF | |||
| SPXT | 106.27 | -0.17 | -0.16% |
| ProShares S&P 500® ex-Technology | |||
| QQA | 53.84 | -0.10 | -0.19% |
| Invesco QQQ Income Advantage ETF | |||
| SRHR | 53.38 | -0.92 | -1.69% |
| SRH REIT Covered Call ETF | |||